QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
作者信息
Manini Alex F, Raspberry Dara, Hoffman Robert S, Nelson Lewis S
机构信息
New York City Poison Center, New York, NY, USA.
出版信息
J Med Toxicol. 2007 Dec;3(4):178-81. doi: 10.1007/BF03160936.
Abstract
摘要
相似文献
1
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.齐拉西酮和金刚烷胺过量服用后出现QT间期延长和尖端扭转型室速。
J Med Toxicol. 2007 Dec;3(4):178-81. doi: 10.1007/BF03160936.
2
Torsades de pointes associated with ziprasidone.与齐拉西酮相关的尖端扭转型室性心动过速。
Psychosomatics. 2006 May-Jun;47(3):264-8. doi: 10.1176/appi.psy.47.3.264.
3
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].[非典型抗精神病药物治疗中QTc间期延长——一项开放性、非随机调查的结果]
Psychiatr Prax. 2004 Nov;31 Suppl 1:S178-80. doi: 10.1055/s-2004-828465.
4
Ziprasidone in the management of schizophrenia : the QT interval issue in context.齐拉西酮治疗精神分裂症：QT间期问题剖析
CNS Drugs. 2003;17(6):423-30. doi: 10.2165/00023210-200317060-00004.
5
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.一项关于肌内注射齐拉西酮在躁动老年患者中安全性的回顾性研究。
J Clin Psychiatry. 2005 Jul;66(7):928-9. doi: 10.4088/jcp.v66n0717.
6
Torsade de pointes after ziprasidone overdose with coingestants.齐拉西酮过量合并其他物质摄入后发生尖端扭转型室速。
J Clin Psychopharmacol. 2010 Feb;30(1):76-7. doi: 10.1097/JCP.0b013e3181c914d3.
7
QT interval duration and dispersion in children and adolescents treated with ziprasidone.齐拉西酮治疗儿童和青少年的 QT 间期持续时间和离散度。
J Clin Psychiatry. 2011 Jun;72(6):854-60. doi: 10.4088/JCP.10m05990yel. Epub 2011 Mar 8.
8
Ziprasidone and the QTc interval: pharmacokinetic and pharmacodynamic considerations.齐拉西酮与QTc间期：药代动力学及药效学考量
Psychopharmacol Bull. 2001 Autumn;35(4):66-79.
9
Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.阿米舒必利过量常与 QT 间期延长和尖端扭转型室性心动过速有关。
J Clin Psychopharmacol. 2010 Aug;30(4):391-5. doi: 10.1097/JCP.0b013e3181e5c14c.
10
[QT prolongation and second-generation antipsychotics: overdose and therapeutic dosage].[QT间期延长与第二代抗精神病药物：过量用药与治疗剂量]
Therapie. 2004 Sep-Oct;59(5):558-61. doi: 10.2515/therapie:2004095.
引用本文的文献
1
Drug Interactions of Psychiatric and COVID-19 Medications.精神科药物与新冠治疗药物的药物相互作用
Basic Clin Neurosci. 2020 Mar-Apr;11(2):185-200. doi: 10.32598/bcn.11.covid19.2500.1. Epub 2020 Apr 27.
2
Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.老年帕金森病患者药物治疗的安全性和耐受性。
Drugs Aging. 2019 Jun;36(6):511-530. doi: 10.1007/s40266-019-00654-z.
3
Parkinson's disease between internal medicine and neurology.内科与神经科之间的帕金森病。
J Neural Transm (Vienna). 2016 Jan;123(1):3-17. doi: 10.1007/s00702-015-1443-z. Epub 2015 Aug 23.
4
QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.第二代抗精神病药和抗抑郁药相关的QTc间期延长及尖端扭转型室性心动过速：一项综述
CNS Drugs. 2014 Oct;28(10):887-920. doi: 10.1007/s40263-014-0196-9.
5
Minimizing cardiovascular adverse effects of atypical antipsychotic drugs in patients with schizophrenia.将精神分裂症患者使用非典型抗精神病药物时的心血管不良反应降至最低。
Cardiol Res Pract. 2014;2014:273060. doi: 10.1155/2014/273060. Epub 2014 Feb 4.
6
Acute respiratory distress syndrome: A rare presentation of amantadine toxicity.急性呼吸窘迫综合征：金刚烷胺中毒的一种罕见表现。
Am J Case Rep. 2014 Jan 2;15:1-3. doi: 10.12659/AJCR.889931. eCollection 2014.
7
Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.非典型抗精神病药物过量：临床表现、毒性机制及处理。
CNS Drugs. 2012 Jul 1;26(7):601-11. doi: 10.2165/11631640-000000000-00000.
8
Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning.疑似中毒患者不良心血管事件的心电图预测指标
J Med Toxicol. 2010 Jun;6(2):106-15. doi: 10.1007/s13181-010-0074-x.
本文引用的文献
1
Ziprasidone: efficacy and safety in patients with bipolar disorder.齐拉西酮：双相情感障碍患者的疗效与安全性
Expert Rev Neurother. 2006 Aug;6(8):1129-38. doi: 10.1586/14737175.6.8.1129.
2
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.肌肉注射齐拉西酮治疗老年精神分裂症患者的急性精神病性激越
Am J Geriatr Psychiatry. 2006 Jul;14(7):629-33. doi: 10.1097/01.JGP.0000216325.42721.99.
3
Torsades de pointes associated with ziprasidone.与齐拉西酮相关的尖端扭转型室性心动过速。
Psychosomatics. 2006 May-Jun;47(3):264-8. doi: 10.1176/appi.psy.47.3.264.
4
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.齐拉西酮治疗精神分裂症敌意症状的疗效：随机开放标签研究数据的事后分析
J Clin Psychiatry. 2006 Apr;67(4):638-42. doi: 10.4088/jcp.v67n0415.
5
Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.非典型抗精神病药物治疗躁狂症：随机安慰剂对照试验的荟萃分析。
J Clin Psychiatry. 2006 Apr;67(4):509-16. doi: 10.4088/jcp.v67n0401.
6
From clinical research to clinical practice: a 4-year review of ziprasidone.从临床研究到临床实践：齐拉西酮的四年回顾
CNS Spectr. 2005 Nov;10(11 Suppl 17):1-20. doi: 10.1017/s1092852900019842.
7
Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam.急诊科急性未分化躁动的管理：氟哌利多、齐拉西酮和咪达唑仑的随机双盲试验
Acad Emerg Med. 2005 Dec;12(12):1167-72. doi: 10.1197/j.aem.2005.07.017. Epub 2005 Nov 10.
8
Schizophrenia, antipsychotic drugs, and cardiovascular disease.精神分裂症、抗精神病药物与心血管疾病
J Clin Psychiatry. 2005;66 Suppl 6:5-10.
9
Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
J Psychopharmacol. 2005 Mar;19(2):205-6. doi: 10.1177/0269881105049042.
10
Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.精神药物诱发的尖端扭转型室速及其危险因素的患病率。
Acta Psychiatr Scand. 2005 Mar;111(3):171-6. doi: 10.1111/j.1600-0447.2004.00469.x.
Zotero 插件